📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Endpoint Health

1.1 - Company Overview

Endpoint Health Logo

Endpoint Health

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of precision immunology solutions, including targeted therapeutics tailored to patient biology for immune-mediated diseases, companion diagnostics to personalize treatment, a precision immunology ecosystem with pharma, biotech, diagnostics providers and clinical data registries, and clinical collaborations with over 60 global health systems to develop precision therapies.

Products and services

  • Companion Diagnostics: Clinically integrated diagnostic products architected to work alongside targeted therapies, delivering patient-specific guidance to personalize treatment for patients
  • Precision Immunology Ecosystem: Interoperable collaborative network connecting pharma, biotech, diagnostics providers, and clinical data registries to advance precision medicine development for immune-mediated illnesses through shared datasets and coordinated clinical insights
  • Targeted Therapeutics: Custom-engineered therapies developed and commercialized to match individual patient biology and clinical needs, producing precision treatments specifically for immune-mediated diseases

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Endpoint Health

Resolvyx Logo

Resolvyx

HQ: United States Website
  • Description: Provider of therapeutics based on small molecule lipid mediators for the treatment of inflammatory diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Resolvyx company profile →
CalciMedica Logo

CalciMedica

HQ: United States Website
  • Description: Provider of CRAC channel inhibitor therapies for acute and chronic inflammatory diseases, including Auxora, an IV CRAC inhibitor in development for acute pancreatitis, asparaginase-induced pancreatic toxicity, acute kidney injury, and ARDS, and oral CRAC inhibitors for conditions such as chronic pancreatitis and rheumatoid arthritis. Conducts clinical trials including CARPO, CRSPA, KOURAGE, and CARDEA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CalciMedica company profile →
180 Life Sciences Logo

180 Life Sciences

HQ: United States Website
  • Description: Provider of novel drug development focused on treating distinct inflammatory diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 180 Life Sciences company profile →
BioSenic Logo

BioSenic

HQ: United States Website
  • Description: Provider of therapies addressing innate immunity, inflammation, and organ/function repair, including arsenic trioxide-based treatments for autoimmune diseases and chronic graft versus host disease (ArsciCor, an oral formulation with rapid gastrointestinal solubilization and optimal bioavailability), cell therapy products for major bone defects and maxillofacial applications, and a Phase III trial of oral arsenic trioxide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioSenic company profile →
Stromedix Logo

Stromedix

HQ: United States Website
  • Description: Provider of drugs targeting fibrosis, organ failure, and cancer, initially focused on chronic indications, with plans to expand into related settings such as acute organ failure and cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Stromedix company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Endpoint Health

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Endpoint Health

2.2 - Growth funds investing in similar companies to Endpoint Health

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Endpoint Health

4.2 - Public trading comparable groups for Endpoint Health

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Endpoint Health

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Endpoint Health

What does Endpoint Health do?

Endpoint Health is a provider of precision immunology solutions, including targeted therapeutics tailored to patient biology for immune-mediated diseases, companion diagnostics to personalize treatment, a precision immunology ecosystem with pharma, biotech, diagnostics providers and clinical data registries, and clinical collaborations with over 60 global health systems to develop precision therapies.

Who are Endpoint Health's competitors?

Endpoint Health's competitors and similar companies include Resolvyx, CalciMedica, 180 Life Sciences, BioSenic, and Stromedix.

Where is Endpoint Health headquartered?

Endpoint Health is headquartered in United States.

How many employees does Endpoint Health have?

Endpoint Health has 1,000 employees 🔒.

When was Endpoint Health founded?

Endpoint Health was founded in 2010 🔒.

What sector and industry vertical is Endpoint Health in?

Endpoint Health is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Endpoint Health

Who are the top strategic acquirers in Endpoint Health's sector and industry

Top strategic M&A buyers and acquirers in Endpoint Health's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Endpoint Health?

Top strategic M&A buyers groups and sectors for Endpoint Health include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Endpoint Health's sector and industry vertical

Which are the top PE firms investing in Endpoint Health's sector and industry vertical?

Top PE firms investing in Endpoint Health's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Endpoint Health's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Endpoint Health's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Endpoint Health's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Endpoint Health include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Endpoint Health's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Endpoint Health?

The key public trading comparables and valuation benchmarks for Endpoint Health include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Endpoint Health for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Endpoint Health with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Endpoint Health's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Endpoint Health with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Endpoint Health's' sector and industry vertical?

Access recent funding rounds and capital raises in Endpoint Health's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Endpoint Health

Launch login modal Launch register modal